COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417 in Combination With Dexamethasone and Carfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Protocol No
BEIGENE-BGB-11417-105
Principal Investigator
Binod Dhakal
Phase
I/II
Summary
This study will look at the safety and efficacy of an investigational drug currently known as BGB-11417 when given together with a drug called dexamethasone or when given together with dexamethasone and carfilzomib.
Description
A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to
Determine the Safety and Efficacy of BGB-11417 in Combination With Dexamethasone andCarfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL